New approaches and Innovation in Lipid Services– managing the high-risk patient in 2022 and beyond

This will be Sanofi led educational meeting that will be held via zoom. The speakers are all doctors/professors who are experts in the field of Cardiology. The objectives are: To communicate how HCPs can impact a patient’s CV residual risk in the post-MI follow-up or secondary prevention clinic; To highlight the impact cardiologists can make in the area of secondary prevention for patients in secondary care Discussion will be encouraged after each presentation and the meeting will finish with a debate that will include all three speakers and the chair.